We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+5.97%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$527M
AUM Growth
-$23M
Cap. Flow
-$51M
Cap. Flow %
-9.68%
Top 10 Hldgs %
55.85%
Holding
241
New
56
Increased
30
Reduced
100
Closed
27

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Healthcare 4.46%
3 Industrials 4.11%
4 Energy 3.15%
5 Real Estate 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
101
Cisco
CSCO
$442B
$924K 0.18%
39,422
-56,185
-59% -$1.39M
PWR icon
102
Quanta Services
PWR
$96.5B
$916K 0.17%
33,300
+10,400
+45% +$281K
PPS
103
DELISTED
Post Properties
PPS
$900K 0.17%
20,000
-5,000
-20% -$234K
WMT icon
104
Walmart Inc
WMT
$870B
$896K 0.17%
36,324
-66,108
-65% -$1.67M
DUK icon
105
Duke Energy
DUK
$99.7B
$884K 0.17%
13,233
-31,454
-70% -$2.15M
PNC icon
106
PNC Financial Services
PNC
$101B
$874K 0.17%
12,065
-20,438
-63% -$1.53M
MMM icon
107
3M
MMM
$89.1B
$872K 0.17%
8,731
-14,902
-63% -$1.45M
PG icon
108
Procter & Gamble
PG
$347B
$866K 0.16%
11,463
+158
+1% +$12.6K
SITC icon
109
SITE Centers
SITC
$224M
$864K 0.16%
42,685
-11,642
-21% -$247K
LUMO
110
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$864K 0.16%
5,111
-256
-5% -$41.2K
AVB icon
111
AvalonBay Communities
AVB
$27B
$855K 0.16%
6,724
-11,868
-64% -$1.57M
ETRM
112
DELISTED
EnteroMedics Inc.
ETRM
$819K 0.16%
626
GIS icon
113
General Mills
GIS
$19.7B
$799K 0.15%
16,670
-25,750
-61% -$1.29M
COF icon
114
Capital One
COF
$124B
$778K 0.15%
11,313
-28,351
-71% -$1.91M
BXP icon
115
Boston Properties
BXP
$10.8B
$775K 0.15%
7,250
+3,000
+71% +$317K
JPM icon
116
JPMorgan Chase
JPM
$926B
$766K 0.15%
14,823
-20,905
-59% -$1.12M
OREX
117
DELISTED
Orexigen Therapeutics, Inc.
OREX
$756K 0.14%
12,330
MCD icon
118
McDonald's
MCD
$187B
$750K 0.14%
7,792
-21,680
-74% -$2.12M
MAT icon
119
Mattel
MAT
$4.18B
$739K 0.14%
17,642
-45,338
-72% -$1.94M
VYM icon
120
Vanguard High Dividend Yield ETF
VYM
$80.8B
$734K 0.14%
12,773
+7,373
+137% +$428K
ECYT
121
DELISTED
Endocyte, Inc. Common Stock
ECYT
$733K 0.14%
55,000
-54,100
-50% -$855K
CBL
122
DELISTED
CBL& Associates Properties, Inc.
CBL
$728K 0.14%
+38,100
New +$803K
REG icon
123
Regency Centers
REG
$15.1B
$725K 0.14%
+15,000
New +$756K
KMB icon
124
Kimberly-Clark
KMB
$36.1B
$713K 0.14%
7,898
-30,635
-80% -$2.84M
ICF icon
125
iShares Select U.S. REIT ETF
ICF
$2.08B
$708K 0.13%
18,414
-500
-3% -$19.8K

Similar funds

Bailard's Q3 2013 Portfolio in Review

As of Q3 2013, Bailard held 241 positions worth $527M, down 4.2% from $550M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Bailard withdrew a net $51M in Q3 2013, closing 27 positions and reducing 100 holdings. Its most notable exit was Ligand Pharmaceuticals, an estimated $2.43M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 8.1% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Bailard opened a new position in Invesco DB Commodity Index Tracking Fund worth $47.3M.

  • Bailard's largest Q3 2013 buy was Invesco DB Commodity Index Tracking Fund: 1,837,601 shares worth $47.3M.
  • Bailard added most to Vanguard Total Stock Market ETF in Q3 2013, an estimated $37.2M increase.
  • Bailard's biggest Q3 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $50.7M.
  • Bailard fully exited Ligand Pharmaceuticals in Q3 2013, selling an estimated $2.43M.
  • Bailard's ten largest holdings make up 56% of its $527M portfolio in Q3 2013.
  • Bailard opened 56 new positions and closed 27 in Q3 2013.
  • Bailard's portfolio value fell 4.2% quarter-over-quarter to $527M.

Based on Bailard's 13F filing for Q3 2013, filed 28 Oct 2013.